|
1
|
Lyon P, Keijzer F, Arendt D and Levin M:
Reframing cognition: Getting down to biological basics. Philos
Trans R Soc Lond B Biol Sci. 376(20190750)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Harvey PD: Domains of cognition and their
assessment. Dialogues Clin Neurosci. 21:227–237. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gómez-Gómez ME and Zapico SC: Frailty,
cognitive decline, neurodegenerative diseases and nutrition
interventions. Int J Mol Sci. 20(2842)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
McNicholas N, O'Connell K, Yap SM, Killeen
RP, Hutchinson M and McGuigan C: Cognitive dysfunction in early
multiple sclerosis: A review. QJM. 111:359–364. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Elendu C, Amaechi DC, Elendu TC, Ibhiedu
JO, Egbunu EO, Ndam AR, Ogala F, Ologunde T, Peterson JC,
Boluwatife AI, et al: Stroke and cognitive impairment:
Understanding the connection and managing symptoms. Ann Med Surg
(Lond). 85:6057–6066. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lo JW, Crawford JD, Desmond DW, Bae HJ,
Lim JS, Godefroy O, Roussel M, Kang Y, Jahng S, Köhler S, et al:
Long-Term cognitive decline after stroke: An individual participant
data meta-analysis. Stroke. 53:1318–1327. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cho MH, Shin DW, Chang SA, Lee JE, Jeong
SM, Kim SH, Yun JM and Son K: Association between cognitive
impairment and poor antihypertensive medication adherence in
elderly hypertensive patients without dementia. Sci Rep.
8(11688)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Helvik AS, Barca ML, Bergh S,
Šaltytė-Benth J, Kirkevold Ø and Borza T: The course of depressive
symptoms with decline in cognitive function-A longitudinal study of
older adults receiving in-home care at baseline. BMC Geriatr.
19(231)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jain N, Wang Y, Zhang Y, Jacobsen E,
Andreescu C, Snitz BE, Chang CH and Ganguli M: It goes both ways:
The relationship between anxiety and mild cognitive impairment. Int
J Geriatr Psychiatry. 38(e5899)2023.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Kwon KY, Park S, Kim RO, Lee EJ and Lee M:
Associations of cognitive dysfunction with motor and non-motor
symptoms in patients with de novo Parkinson's disease. Sci Rep.
12(11461)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pais R, Ruano L, P Carvalho O and Barros
H: Global cognitive impairment prevalence and incidence in
community dwelling older adults-A systematic review. Geriatrics
(Basel). 5(84)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tahami Monfared AA, Byrnes MJ, White LA
and Zhang Q: The humanistic and economic burden of Alzheimer's
disease. Neurol Ther. 11:525–551. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lin PJ and Neumann PJ: The economics of
mild cognitive impairment. Alzheimers Dement. 9:58–62.
2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xu T, Dong W, Liu J, Yin P, Wang Z, Zhang
L and Zhou M: Disease burden of Parkinson's disease in China and
its provinces from 1990 to 2021: Findings from the global burden of
disease study 2021. Lancet Reg Health West Pac.
46(101078)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Walton C, King R, Rechtman L, Kaye W,
Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der
Mei I, et al: Rising prevalence of multiple sclerosis worldwide:
Insights from the Atlas of MS, third edition. Mult Scler.
26:1816–1821. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Epstein MA, Achong BG and Barr YM: Virus
particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet.
1:702–703. 1964.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hoover K and Higginbotham K: Epstein-Barr
Virus. In: StatPearls (Internet). StatPearls Publishing, Treasure
Island, FL, 2024.
|
|
18
|
Li Q and Cohen JI: Epstein-Barr virus and
the human leukocyte antigen complex. Curr Clin Microbiol Rep.
6:175–181. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yin H, Qu J, Peng Q and Gan R: Molecular
mechanisms of EBV-driven cell cycle progression and oncogenesis.
Med Microbiol Immunol. 208:573–583. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang N, Zuo Y, Jiang L, Peng Y, Huang X
and Zuo L: Epstein-Barr virus and neurological diseases. Front Mol
Biosci. 8(816098)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Drouin E and Drouin G: The first report of
Alzheimer's disease. Lancet Neurol. 16(687)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
van der Flier WM, de Vugt ME, Smets EMA,
Blom M and Teunissen CE: Towards a future where Alzheimer's disease
pathology is stopped before the onset of dementia. Nat Aging.
3:494–505. 2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hampel H, Mesulam MM, Cuello AC,
Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E and
Khachaturian ZS: Revisiting the cholinergic hypothesis in
Alzheimer's disease: Emerging evidence from translational and
clinical research. J Prev Alzheimers Dis. 6:2–15. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sobue A, Komine O and Yamanaka K:
Neuroinflammation in Alzheimer's disease: Microglial signature and
their relevance to disease. Inflamm Regen. 43(26)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Schreiner TG and Popescu BO: Amyloid beta
dynamics in biological fluids-Therapeutic impact. J Clin Med.
10(5986)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Muralidar S, Ambi SV, Sekaran S,
Thirumalai D and Palaniappan B: Role of tau protein in Alzheimer's
disease: The prime pathological player. Int J Biol Macromol.
163:1599–1617. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Patrick KL, Bell SL, Weindel CG and Watson
RO: Exploring the ‘multiple-hit hypothesis’ of neurodegenerative
disease: Bacterial infection comes up to bat. Front Cell Infect
Microbiol. 9(138)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Carbone I, Lazzarotto T, Ianni M,
Porcellini E, Forti P, Masliah E, Gabrielli L and Licastro F:
Herpes virus in Alzheimer's disease: Relation to progression of the
disease. Neurobiol Aging. 35:122–129. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Shim SM, Cheon HS, Jo C, Koh YH, Song J
and Jeon JP: Elevated Epstein-Barr virus antibody level is
associated with cognitive decline in the Korean elderly. J
Alzheimers Dis. 55:293–301. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Huang SY, Yang YX, Kuo K, Li HQ, Shen XN,
Chen SD, Cui M, Tan L, Dong Q and Yu JT: Herpesvirus infections and
Alzheimer's disease: A Mendelian randomization study. Alzheimers
Res Ther. 13(158)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Leonardo S and Fregni F: Association of
inflammation and cognition in the elderly: A systematic review and
meta-analysis. Front Aging Neurosci. 15(1069439)2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tiwari D, Singh VK, Baral B, Pathak DK,
Jayabalan J, Kumar R, Tapryal S and Jha HC: Indication of
neurodegenerative cascade initiation by amyloid-like
aggregate-forming EBV proteins and peptide in Alzheimer's disease.
ACS Chem Neurosci. 12:3957–3967. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jakhmola S and Jha HC: Glial cell response
to Epstein-Barr Virus infection: A plausible contribution to
virus-associated inflammatory reactions in the brain. Virology.
559:182–195. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gate D, Saligrama N, Leventhal O, Yang AC,
Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los
Santos MB, et al: Clonally expanded CD8 T cells patrol the
cerebrospinal fluid in Alzheimer's disease. Nature. 577:399–404.
2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tiwari D, Mittal N and Jha HC: Unraveling
the links between neurodegeneration and Epstein-Barr virus-mediated
cell cycle dysregulation. Curr Res Neurobiol.
3(100046)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Koseoglu MM, Norambuena A, Sharlow ER,
Lazo JS and Bloom GS: Aberrant neuronal cell cycle re-entry: The
pathological confluence of Alzheimer's Disease and brain insulin
resistance, and its relation to cancer. J Alzheimers Dis. 67:1–11.
2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Malhotra N, Gupta R and Kumar P:
Pharmacological relevance of CDK inhibitors in Alzheimer's disease.
Neurochem Int. 148(105115)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sun X, Zhang H, Yao D, Xu Y, Jing Q, Cao
S, Tian L and Li C: Integrated bioinformatics analysis identifies
hub genes associated with viral infection and Alzheimer's disease.
J Alzheimers Dis. 85:1053–1061. 2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Mizutani K, Miyata M, Shiotani H, Kameyama
T and Takai Y: Nectin-2 in general and in the brain. Mol Cell
Biochem. 477:167–180. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Shinjyo N, Kagaya W and Pekna M:
Interaction between the complement system and infectious agents-A
potential mechanistic link to neurodegeneration and dementia. Front
Cell Neurosci. 15(710390)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Blackhurst BM and Funk KE: Viral pathogens
increase risk of neurodegenerative disease. Nat Rev Neurol.
19:259–260. 2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ogawa H, Fujikura D, Namba H, Yamashita N,
Honda T and Yamada M: Nectin-2 acts as a viral entry mediated
molecule that binds to human herpesvirus 6B Glycoprotein B.
Viruses. 14(160)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Blujus JK, Korthauer LE, Awe E, Frahmand M
and Driscoll I: Single nucleotide polymorphisms in Alzheimer's
disease risk genes are associated with intrinsic connectivity in
middle age. J Alzheimers Dis. 78:309–320. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Gu X, Dou M, Cao B, Jiang Z and Chen Y:
Peripheral level of CD33 and Alzheimer's disease: A bidirectional
two-sample Mendelian randomization study. Transl Psychiatry.
12(427)2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Gouda NA, Elkamhawy A and Cho J: Emerging
therapeutic strategies for Parkinson's disease and future
prospects: A 2021 update. Biomedicines. 10(371)2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Petrijan T, Zmazek J and Menih M:
Parkinson's disease non-motor subtypes classification in a group of
Slovenian patients: Actuarial vs. data-driven approach. J Clin Med.
12(7434)2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Gonzalez-Latapi P, Bayram E, Litvan I and
Marras C: Cognitive impairment in Parkinson's disease:
Epidemiology, clinical profile, protective and risk factors. Behav
Sci (Basel). 11(74)2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Aldridge GM, Birnschein A, Denburg NL and
Narayanan NS: Parkinson's disease dementia and dementia with Lewy
bodies have similar neuropsychological profiles. Front Neurol.
9(123)2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Woulfe J, Hoogendoorn H, Tarnopolsky M and
Muñoz DG: Monoclonal antibodies against Epstein-Barr virus
cross-react with alpha-synuclein in human brain. Neurology.
55:1398–1401. 2000.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Bu XL, Wang X, Xiang Y, Shen LL, Wang QH,
Liu YH, Jiao SS, Wang YR, Cao HY, Yi X, et al: The association
between infectious burden and Parkinson's disease: A case-control
study. Parkinsonism Relat Disord. 21:877–881. 2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Funayama M, Nishioka K, Li Y and Hattori
N: Molecular genetics of Parkinson's disease: Contributions and
global trends. J Hum Genet. 68:125–130. 2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Solomon AJ, Marrie RA, Viswanathan S,
Correale J, Magyari M, Robertson NP, Saylor DR, Kaye W, Rechtman L,
Bae E, et al: Global barriers to the diagnosis of multiple
sclerosis: Data from the multiple sclerosis International
Federation Atlas of MS, Third Edition. Neurology. 101:e624–e635.
2023.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Qian Z, Li Y, Guan Z, Guo P, Zheng K, Du
Y, Yin S, Chen B, Wang H, Jiang J, et al: Global, regional, and
national burden of multiple sclerosis from 1990 to 2019: Findings
of global burden of disease study 2019. Front Public Health.
11(1073278)2023.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Gustavsen S, Olsson A, Søndergaard HB,
Andresen SR, Sørensen PS, Sellebjerg F and Oturai A: The
association of selected multiple sclerosis symptoms with disability
and quality of life: A large Danish self-report survey. BMC Neurol.
21(317)2021.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Zeydan B and Kantarci OH: Progressive
forms of multiple sclerosis: Distinct entity or age-dependent
phenomena. Neurol Clin. 36:163–171. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Mato-Abad V, Labiano-Fontcuberta A,
Rodríguez-Yáñez S, García-Vázquez R, Munteanu CR, Andrade-Garda J,
Domingo-Santos A, Galán Sánchez-Seco V, Aladro Y, Martínez-Ginés
ML, et al: Classification of radiologically isolated syndrome and
clinically isolated syndrome with machine-learning techniques. Eur
J Neurol. 26:1000–1005. 2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Nourbakhsh B and Mowry EM: Multiple
sclerosis risk factors and pathogenesis. Continuum (Minneap Minn).
25:596–610. 2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Bar-Or A, Banwell B, Berger JR and
Lieberman PM: Guilty by association: Epstein-Barr virus in multiple
sclerosis. Nat Med. 28:904–906. 2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Bjornevik K, Cortese M, Healy BC, Kuhle J,
Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL and
Ascherio A: Longitudinal analysis reveals high prevalence of
Epstein-Barr virus associated with multiple sclerosis. Science.
375:296–301. 2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Pender MP, Csurhes PA, Burrows JM and
Burrows SR: Defective T-cell control of Epstein-Barr virus
infection in multiple sclerosis. Clin Transl Immunology.
6(e126)2017.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Soldan SS and Lieberman PM: Epstein-Barr
virus and multiple sclerosis. Nat Rev Microbiol. 21:51–64.
2023.PubMed/NCBI View Article : Google Scholar
|
|
62
|
van Langelaar J, Wierenga-Wolf AF, Samijn
JPA, Luijks CJM, Siepman TA, van Doorn PA, Bell A, van Zelm MC,
Smolders J and van Luijn MM: The association of Epstein-Barr virus
infection with CXCR3+ B-cell development in multiple sclerosis:
Impact of immunotherapies. Eur J Immunol. 51:626–633.
2021.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Afrasiabi A, Parnell GP, Fewings N,
Schibeci SD, Basuki MA, Chandramohan R, Zhou Y, Taylor B, Brown DA,
Swaminathan S, et al: Evidence from genome-wide association studies
implicates reduced control of Epstein-Barr virus infection in
multiple sclerosis susceptibility. Genome Med.
11(26)2019.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Sadigh-Eteghad S, Abbasi Garravnd N,
Feizollahi M and Talebi M: The expanded disability status scale
score and demographic indexes are correlated with the severity of
cognitive impairment in multiple sclerosis patients. J Clin Neurol.
17:113–120. 2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Brochet B and Ruet A: Cognitive impairment
in multiple sclerosis with regards to disease duration and clinical
phenotypes. Front Neurol. 10(261)2019.PubMed/NCBI View Article : Google Scholar
|
|
66
|
DeLuca GC, Yates RL, Beale H and Morrow
SA: Cognitive impairment in multiple sclerosis: Clinical,
radiologic and pathologic insights. Brain Pathol. 25:79–98.
2015.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Benedict RHB, Amato MP, DeLuca J and
Geurts JJG: Cognitive impairment in multiple sclerosis: Clinical
management, MRI, and therapeutic avenues. Lancet Neurol.
19:860–871. 2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Nacu-Florescu AI, Schreiner OD and
Schreiner TG: Screening tests for the evaluation of cognitive
impairment in multiple sclerosis patients. Ro J Neurol 21(4).
doi.org/10.37897/RJN.2022.4.1.
|
|
69
|
Aloisi F, Giovannoni G and Salvetti M:
Epstein-Barr virus as a cause of multiple sclerosis: Opportunities
for prevention and therapy. Lancet Neurol. 22:338–349.
2023.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Vindegaard N, Petersen LV, Lyng-Rasmussen
BI, Dalsgaard S and Benros ME: Infectious mononucleosis as a risk
factor for depression: A nationwide cohort study. Brain Behav
Immun. 94:259–265. 2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Lanz TV, Brewer RC, Ho PP, Moon JS, Jude
KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, et
al: Clonally expanded B cells in multiple sclerosis bind EBV EBNA1
and GlialCAM. Nature. 603:321–327. 2022.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Harley JB, Chen X, Pujato M, Miller D,
Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, et
al: Transcription factors operate across disease loci, with EBNA2
implicated in autoimmunity. Nat Genet. 50:699–707. 2018.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Virtanen JO, Wohler J, Fenton K, Reich DS
and Jacobson S: Oligoclonal bands in multiple sclerosis reactive
against two herpesviruses and association with magnetic resonance
imaging findings. Mult Scler. 20:27–34. 2014.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Angelini DF, Serafini B, Piras E, Severa
M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F,
Centonze D, et al: Increased CD8+ T cell response to Epstein-Barr
virus lytic antigens in the active phase of multiple sclerosis.
PLoS Pathog. 9(e1003220)2013.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Pavlasova G and Mraz M: The regulation and
function of CD20: An ‘enigma’ of B-cell biology and targeted
therapy. Haematologica. 105:1494–1506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
de Sèze J, Maillart E, Gueguen A, Laplaud
DA, Michel L, Thouvenot E, Zephir H, Zimmer L, Biotti D and Liblau
R: Anti-CD20 therapies in multiple sclerosis: From pathology to the
clinic. Front Immunol. 14(1004795)2023.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Berger JR and Kakara M: The elimination of
circulating Epstein-Barr virus infected B cells underlies anti-CD20
monoclonal antibody activity in multiple sclerosis: A hypothesis.
Mult Scler Relat Disord. 59(103678)2022.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Mazziotta C, Tognon M, Martini F,
Torreggiani E and Rotondo JC: Probiotics mechanism of action on
immune cells and beneficial effects on human health. Cells.
12(184)2023.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Hori T, Matsuda K and Oishi K: Probiotics:
A dietary factor to modulate the gut microbiome, host immune
system, and gut-brain interaction. Microorganisms.
8(1401)2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Intili G, Paladino L, Rappa F, Alberti G,
Plicato A, Calabrò F, Fucarino A, Cappello F, Bucchieri F,
Tomasello G, et al: From dysbiosis to neurodegenerative diseases
through different communication pathways: An overview. Biology
(Basel). 12(195)2023.PubMed/NCBI View Article : Google Scholar
|
